Provided by Tiger Trade Technology Pte. Ltd.

Immunome Inc.

28.52
+0.44001.57%
Post-market: 28.00-0.5200-1.82%19:30 EDT
Volume:848.79K
Turnover:24.39M
Market Cap:3.24B
PE:-11.48
High:29.30
Open:28.46
Low:28.13
Close:28.08
52wk High:30.06
52wk Low:8.67
Shares:113.58M
Float Shares:108.11M
Volume Ratio:0.61
T/O Rate:0.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4851
EPS(LYR):-2.4315
ROE:-64.03%
ROA:-37.78%
PB:6.17
PE(LYR):-11.73

Loading ...

Immunome (IMNM) Receives a New Rating from Barclays

TIPRANKS
·
May 28

Immunome management presents at Goldman Sachs Global Healthcare Conference

Reuters
·
May 27

Immunome Expands Oncology Pipeline With New Phase 1 IM-1617 Trial

TIPRANKS
·
May 23

Stock Track | Immunome Inc. Soars 6.28% in Pre-market on Insider Buying

Stock Track
·
May 19

Immunome director Jean Jacques Bienaime buys 5,000 shares for $103,500

Reuters
·
May 19

LifeSci Capital Keeps Their Buy Rating on Immunome (IMNM)

TIPRANKS
·
May 16

Immunome Is Maintained at Outperform by Leerink Partners

Dow Jones
·
May 16

Analysts Offer Insights on Healthcare Companies: Immunome (IMNM), Aveanna Healthcare Holdings (AVAH) and QT Imaging Holdings (QTI)

TIPRANKS
·
May 14

Analysts Conflicted on These Healthcare Names: Kyverna Therapeutics, Inc. (KYTX), Immunome (IMNM) and Prime Medicine, Inc. (PRME)

TIPRANKS
·
May 13

Immunome (IMNM) Gets a Buy from Guggenheim

TIPRANKS
·
May 13

Immunome Price Target Maintained With a $40.00/Share by HC Wainwright & Co.

Dow Jones
·
May 13

Immunome reports Q1 EPS (48c), consensus (54c)

TIPRANKS
·
May 13

Analysts Are Bullish on Top Healthcare Stocks: Immunome (IMNM), Kalaris Therapeutics (KLRS)

TIPRANKS
·
May 13

Immunome Q1 EPS $(0.48) Beats $(0.57) Estimate

Benzinga Earnings
·
May 13

Immunome Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

Immunome Q1 net loss widens to $53.84 million

Reuters
·
May 13

Immunome Q1 Operating Expenses USD 59.331 Million

THOMSON REUTERS
·
May 13

Assessing Immunome (IMNM) Valuation As Premium P/B And DCF Signals Point In Different Directions

Simply Wall St.
·
May 08

Immunome grants 450,000 inducement stock options to 19 new employees at $22.73/share

Reuters
·
May 06

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 06